Cannabis industry insiders brace for potential fallout as health officials report new vaping deaths, issue warnings

美国卫生部发布大麻吸食性死亡警告,预计汽化器制造商受影响

2019-09-09 08:33:54 mjbizdaily

本文共3603个字,阅读需10分钟

U.S. health officials were once again cautioning the public to refrain from using vaping products as related respiratory illnesses and even deaths continued to be disclosed last week. As of Friday, officials linked at least five fatalities to e-cigarettes and electronic marijuana vaping devices. The outbreak has some in the cannabis industry expecting at least a temporary drop in sales for products such as disposable vape cartridges and, potentially, a new round of regulations for vaporizer makers stemming from concerns over public health. The states that have reported vaping-related lung illnesses to the Centers for Disease Control and Prevention (CDC) are Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia and Wisconsin. One of the latest cases, reported Tuesday in Oregon, linked a man’s death in July to “reports that the individual … had recently used an e-cigarette or vaping device containing cannabis purchased from a cannabis dispensary,” according to a statement from the Oregon Health Authority (OHA). An OHA spokesman wrote in an email to Marijuana Business Daily that authorities do not yet know the name of the store where the suspect cannabis was purchased but confirmed that it was a legal, licensed retailer. “What we don’t know for sure is what, exactly, caused the individual’s death – just that the individual shopped at a dispensary before falling ill,” OHA spokesman Jonathan Modie wrote. “We believe the individual used a vaping device containing a cannabis product before getting sick.” The symptoms of the Oregon patient were consistent with those being investigated by the CDC and resemble other newly reported deaths in Illinois, Indiana and Minnesota as well as a possible vape-related death in Los Angeles County, according to The Washington Post. No single vaping device, liquid or ingredient has been tied to all the illnesses, officials said. Meanwhile, a preliminary report published Friday in the New England Journal of Medicine about pulmonary illness related to e-cigarette use in Illinois and Wisconsin noted 84% of the 53 case patients analyzed “reported having used tetrahydrocannabinol (THC) products in e-cigarette devices, although a wide variety of products and devices was reported.” At this point, there are far more questions than answers, according to all the latest statements from the CDC and other health authorities. “We’re all wondering if this is new or just newly recognized,” Dana Meaney-Delman of the CDC told reporters Friday. An Illinois health official, Jennifer Layden, said officials there don’t know when such illnesses first began, but she said there has been a marked increase since spring. The Washington Post reported that an additive, vitamin E acetate, was found in a number of cannabis samples tested in New York state, but The New York Times reported that some of the 100 products used by afflicted patients tested negative for that additive, so the precise cause of the illness still remains unclear to officials. There’s even some dissent among marijuana industry watchers as to how big an impact the issue will have for the cannabis industry, even if state-legal marijuana vaporizer products are ultimately found not responsible. Industry: True culprit is black market The Oregon case notwithstanding, most of the other cases appear connected to cannabis products or e-cigarettes purchased from illicit dealers or unlicensed marijuana shops, to the point that the CDC has warned consumers not to buy or use vape products “off the street.” As a consequence, state-legal cannabis vaporizer companies and other industry observers are taking to heart that blame for the outbreak may not fall on them. “I’ve seen this kind of media blitz for the past 10 years happen once every six months,” said Arnaud Dumas de Rauly, CEO of New York-based The Blinc Group, a vaporizer company. “It’s all over the media for two, three, four weeks. “This might last a little bit longer because it mixes nicotine vaping and cannabis, but I think it’s just a fad. It’s going to pass and everyone is going to forget about it in two months.” Dumas de Rauly, who also chairs the ISO Committee on Vaping Standards and CEN Vaping Standards Committee, pointed to statements by both physicians watching the outbreak and a former commissioner of the U.S. Food and Drug Administration (FDA) noting the majority of illnesses were linked to street products diluted with some new additive, perhaps such as vitamin E acetate, as The Washington Post story indicated. Vitamin E acetate is not used in standard cannabis oil or vape cartridge production, Dumas de Rauly said, and provides more evidence the problem is coming from illegal actors and not licensed cannabis companies. “That is never used. Vitamin E is what we call a preservative. That’s what you add into cosmetics to make sure the product does not become spoiled,” Dumas de Rauly said. “In no case is this a product that you should be inhaling.” “When you add products like vitamin E … when you add different kind of lipid solvents to the mix, you’re making all of that oil stickier, and that stickiness is going to create these lung illnesses we’re seeing,” he said. “Now, why do people add vitamin E? Because it’s supposed to help with the shelf life.” That’s in direct contrast to lab-tested marijuana vape cartridges, which have been on the market for years without drastic health impacts reported, Dumas de Rauly noted. “All of the patients are saying they bought it off the street. They didn’t buy it in legal, regulated environments,” Dumas de Rauly said. “This is just basic math. … We have substantial data that shows that these products and these vaping illnesses come from the black market. “The culprit here is the black-market product. It’s not the cartridge, it’s not the hardware, it’s not the regulators. It’s the black market.” Collateral damage? That doesn’t mean there won’t be people who point the finger at licensed cannabis businesses, however. Longtime industry opponent Kevin Sabet, president of Smart Approaches to Marijuana (SAM), cited the Oregon case in a Twitter post Thursday: “Pot shops kill. Close them down.” Morgan Paxhia, the managing director of San Francisco-based Poseidon Asset Management, warned the vaping illness outbreak “definitely could throw some cold water on the (vaping) space,” perhaps depending on how many more people get sick and how long the issue lasts. But, Paxhia said, he doesn’t expect any drastic downturn in sales for marijuana vape cartridges or cannabis in general, in part because the vast majority of users haven’t reported negative side effects and the products remain incredibly popular. “If people are getting sick from illicit-market products, pointing the blame at the legal operators is not going to correct the (situation),” he said. “It is likely an unfair characterization of those trying to do things properly and just causes more confusion.” “But I do think it is a risk” that legal MJ companies could get scapegoated for the epidemic, Paxhia added. Dumas de Rauly said he believes the outbreak could lead to a short-term drop in MJ vape cartridge sales, though he noted it’s unlikely it would hit the industry’s bottom line broadly over the long term. Jim Makoso, vice president of Lucid Lab Group in Washington state, and Dumas de Rauly emphasized that numerous studies have concluded vaping is far safer than smoking when it comes to cannabis ingestion. Makoso said that marijuana companies dedicated to making consumer-safe products will remain fine in the long haul, even if they need to invest in additional research and development or update manufacturing processes. “In the short term, I anticipate that vape sales will pare back somewhat as a short-term response to what’s happening out there,” he said, “but by and large, there are very few connections to these illnesses and specifically cannabis products. “Anytime that any product in the cannabis industry could be connected to an illness … we should take it very seriously. I don’t want to jump to conclusions, because at this point it’s just conjecture.” Regulatory backlash? There’s already been a crackdown in Michigan on flavored e-cigarette oils by Gov. Gretchen Whitmer, who said she was issuing a ban to keep such products from appealing to teenagers. The move was motivated at least in part by the vaping-illness epidemic as part of a broader push to protect public health. The ban could signal an expanded regulatory backlash against the vaping industry at large, marijuana industry watchers said. Makoso noted the vaping-illness outbreak could even motivate the FDA or Congress to get directly involved in vaping industry oversight. According to The Washington Post, U.S. Sen. Dick Durbin, a Democrat from Illinois, was calling Friday for FDA action. Dumas de Rauly said further regulation is exactly where he sees the situation leading. “The most impactful points for businesses are going to be the politicians and the regulatory agencies who are going to have to bump up their policing and enforcement of current regulations, if not create even more stringent” regulations to govern the vaping industry, he said. “The idea of people getting sick specifically because of vaping … is definitely going to have an impact in the cannabis industry. What that impact is, is yet to be determined,” Makoso said. Makoso and Dumas de Rauly said the best way for cannabis companies to get out in front of the situation is to talk about it as much as possible and educate the public on the rigorous testing that state-legal MJ products undergo to ensure consumer safety. “This is what the cannabis industry should be using this story for,” Dumas de Rauly said. “This should prove that people need to go buy from legal, regulated sources.” Bart Schaneman and the Associated Press contributed to this story. John Schroyer can be reached at [email protected] Bart Schaneman can be reached at [email protected]
美国卫生官员再次警告公众不要使用吸食产品作为相关的呼吸系统疾病,甚至死亡继续在上周披露。 截至上周五,官员们将至少5人死亡与电子香烟和电子大麻吸食装置联系起来。 大麻行业的一些人预计,一次性药盒等产品的销售至少会暂时下降,同时,由于对公共卫生的担忧,可能会出现针对汽化器制造商的新一轮监管规定。 向疾病控制和预防中心报告了与吸食有关的肺病的州是阿肯色州、加利福尼亚州、科罗拉多州、康涅狄格州、特拉华州、弗洛里达州、佐治亚州、伊利诺伊州、印第安纳州、爱荷华州、堪萨斯州、肯塔基州、路易斯安那州、马里兰州、密歇根州、明尼苏达州、蒙大拿州、内布拉斯加州、新泽西州、纽约州、纽约州、北卡罗来纳州、俄亥俄州、俄勒冈州、宾夕法尼亚州。南卡罗来纳州、田纳西州、德克萨斯、犹他州、佛蒙特州、弗吉尼亚州、西弗吉尼亚州和威斯康辛。 俄勒冈州卫生管理局( OHA )的一份声明称,最新的一起病例是周二在俄勒冈州报告的,其中一例与7月份一名男子的死亡有关,“报告称,此人最近使用了一种电子香烟或含有大麻药房购买的大麻的吸食设备”。 OHA 的一位发言人在给《大麻商业日报》的一封电子邮件中写道,当局还不知道购买可疑大麻的商店的名称,但证实这是一家合法的特许零售商。 OHA 发言人乔纳森•莫迪( Jonathan Modie )写道:“我们不确定的是,到底是什么原因导致了这个人的死亡——就是这个人在生病前在药房购物。” “我们相信这个人在生病前使用了含有大麻产品的吸食设备。” 据《华盛顿邮报》报道,俄勒冈病人的症状与疾病预防控制中心(CDC)控制中心正在调查的症状一致,类似于伊利诺斯州、印第安纳州和明尼苏达州的其他新报告的死亡病例,以及洛杉矶县可能发生的与吸食有关的死亡病例。 官员们说,没有一种单一的灭活设备、液体或成分与所有疾病有关。 与此同时,周五发表在《新英格兰医学杂志》上的一份初步报告指出,53名被分析的患者中有84%的人“报告说在电子烟设备中使用了四氢大麻酚( THC )产品,尽管有大量的产品和设备被报道。” 根据疾病预防控制中心(CDC)中心和其他卫生当局的最新声明,目前的问题远远多于答案。 “我们都在想,这是新的还是刚刚被承认的,”美国疾病预防控制中心的达娜·梅利-德尔曼星期五对记者说。 伊利诺伊州一位卫生官员 Jennifer Layden 说,官员们不知道这种疾病是从什么时候开始的,但她说,自春季以来已经有了显著的增长。 《华盛顿邮报》报道说,在纽约州检测的一些大麻样本中发现了一种添加剂,即维生素 E 醋酸盐,但《纽约时报》报道说,受影响患者使用的100种产品中,有一些产品对这种添加剂检测为阴性,因此官方仍不清楚这种疾病的确切原因。 大麻行业观察人士甚至对这个问题对大麻行业的影响有一些不同意见,即使最终发现国家法律规定的大麻蒸发产品并不负责。 行业:真正的罪魁祸首是黑市 尽管俄勒冈州的案件,大多数其他案件似乎与从非法交易商或无许可证的大麻商店购买的大麻产品或电子香烟有关,以至于疾控中心警告消费者不要“在街上”购买或使用吸食产品。 因此,国家法律规定的大麻汽化公司和其他行业观察人士正将疫情爆发的原因归咎于他们。 “过去10年来,我看到这种媒体热潮每6个月就会发生一次,”总部位于纽约的蒸发公司 The Blinc Group 的首席执行官阿诺德•杜马斯•德劳利( Arnaud Dumas de Rauly )表示。“整个媒体都有两、三、四周的时间。 “这可能会持续更长时间,因为它混合了尼古丁吸食和大麻,但我认为这只是一种时尚。它将会过去,而且每个人都会在两个月内忘记它。” 国际标准化组织真空标准委员会和 CEN 真空标准委员会主席 Dumas de Rauly 指出,两位医生都在观察疫情,美国食品药品监督管理局(Food and Drug Administration)( FDA )前专员指出,大多数疾病都与街道产品有关,这些产品被一些新的添加剂摊薄。正如《华盛顿邮报》报道所指出的那样,或许就像维生素 E 醋酸盐。 Dumas de Rauly 说,维生素 E 醋酸盐不能用于标准的大麻油或 vape 药盒生产,并提供了更多的证据表明问题来自非法行为者,而不是特许的大麻公司。 “这是从未使用过的。维生素 E 是我们所说的防腐剂。这就是你在化妆品中添加的东西,以确保产品不会变质,” Dumas de Rauly 说。 “在任何情况下,这都不是你应该吸入的产品。” “当你添加维生素 E 等产品时……当你在混合物中添加不同种类的脂类溶剂时,你会使所有的油黏性变得更粘稠,而黏性会导致我们所看到的肺部疾病,”他说。 “现在,为什么人们要添加维生素 E ?因为它应该有助于保质期。” Dumas de Rauly 指出,这与经过实验室测试的大麻药盒形成了直接的对比,这些药盒多年来一直在市场上销售,但没有严重的健康影响。 “所有的病人都说他们是在街上买的。他们没有在合法的、受监管的环境中购买它,” Dumas de Rauly 说。 “这只是基础数学。……我们有大量的数据表明,这些产品和这些疾病来自黑市。 “罪魁祸首是黑市产品。它不是墨盒,不是硬件,不是调节器。这是黑市。” 附带损害? 不过,这并不意味着不会有人指指指手划脚地经营特许大麻业务。 长期的行业竞争对手、大麻智能方法公司( SAM )总裁凯文•萨贝特( KevinSabett )周四在 Twitter 上引用了俄勒冈州的案例:“大麻商店被杀。”关闭他们。” 总部位于旧金山的 Poseidon 资产管理公司( Poseidon Asset Management )董事总经理摩根•帕克希亚( Morgan Paxhia )警告说,这种疾病爆发“肯定会给(吸食)场所带来一些冷水”,这可能取决于更多人患病以及问题持续多久。 但是, Paxhia 说,他并不认为总体上大麻药盒或大麻的销售会出现大幅下滑,部分原因是绝大多数用户没有报告负面的副作用,而且这些产品仍然非常受欢迎。 他说:“如果人们从非法市场产品中患病,把责任归咎于合法经营者,就不会纠正这种情况。”“这很可能是对那些试图正确行事的人的不公平描述,只会造成更多的混乱。” Paxhia 补充说,“但我确实认为这是一种风险”,合法的 MJ 公司可能因疫情而被替罪羊。 杜马斯•德•劳利( Dumas de Rauly )表示,他认为此次疫情可能导致 MJ vape 墨盒销量短期下降,但他指出,从长期来看,不太可能全面触及行业的底线。 华盛顿州 LucidLabGroup 副总裁 Jim Makoso 和 Dumas de Rauly 强调,许多研究得出结论,在大麻摄入方面,吸食比吸烟安全得多。 Makoso 表示,致力于生产消费者安全产品的大麻公司将长期保持良好状态,即使它们需要投资于更多的研发或更新制造工艺。 “从短期来看,我预计,作为对正在发生的事情的短期反应,吸食销售将有所减少,”他说,“但总的来说,与这些疾病,特别是大麻产品的关系很少。 “任何时候大麻行业的任何产品都可能与疾病有关……我们应该非常认真地对待它。我不想得出结论,因为在这一点上,这只是猜测。” 监管反弹? 密歇根州政府已经对口味的电子烟油进行了打击。格雷琴·惠特默说,她正在颁布一项禁令,禁止这些产品吸引青少年。 这一举措至少在一定程度上是由吸食疾病流行引发的,这是保护公共卫生的更广泛努力的一部分。 大麻行业观察人士表示,这一禁令可能标志着监管机构对整个吸食行业的反应扩大。 Makoso 指出,这种疾病的爆发甚至可能促使 FDA 或国会直接参与到行业监管中。 根据《华盛顿邮报》,美国参议员。来自伊利诺伊州的民主党人迪克·德宾星期五呼吁 FDA 采取行动。 杜马斯·德劳里说,进一步的监管正是他认为形势领先的地方。 他表示:“对企业而言,最有影响的因素将是政客和监管机构,它们将不得不加强对现行法规的监管和执行力度,即便不是制定更严格的监管规定”,以管理这个新兴行业。 “人们因吸食而生病的想法肯定会对大麻行业产生影响。影响是什么,还有待确定,” Makoso 说。 Makoso 和 Dumas de Rauly 表示,大麻公司在形势面前走出困境的最佳方式是尽可能多地谈论这一问题,并教育公众了解国家法律规定的 MJ 产品为确保消费者安全而进行的严格测试。 “这是大麻产业应该用这个故事来做的,” Dumas de Rauly 说。“这应该证明,人们需要从合法、受监管的来源购买商品。” BartSchamman 和美联社为这个故事做出了贡献。 John Schroyer 可通过[电子邮件保护]联系 BartSchneman 可以通过[电子邮件保护]联系到.

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文